Archives
o2h Ventures makes an SEIS Investment into Five Alarm Bio to strengthen anti-ageing science 28 February, 2023
Exciting news as o2h Ventures’ portfolio company Small Pharma, unveils positive top-line results of their Phase IIa clinical trial for treating MDD 31 January, 2023
o2h Ventures backed Kuano wins Innovate UK funding for designing the next generation of cancer drugs 18 January, 2023
o2h Ventures invests in Qkine – once again… 22 December, 2022
o2h Ventures backed Turbine raises €20 Million 30 November, 2022
Alevin Therapeutics won the Best Biotech Start-up at the OBN Awards 2022 18 November, 2022
o2h Ventures backed Neurofenix raises $7 Million to transform stroke and brain injury recovery 6 September, 2022
Funding boost for spin-out developing new medicines for life-threatening diseases 29 July, 2022
o2h Ventures makes an SEIS investment into CardiaTec 6 July, 2022